Literature DB >> 2323128

Walking efficiency after cemented and noncemented total hip arthroplasty.

E Mattsson1, L A Broström, D Linnarsson.   

Abstract

Clinical evaluation using the Harris hip score has been supplemented with analysis of walking capacity before and after total hip arthroplasty (THA). Twenty patients were studied, ten of whom were treated with a cemented Charnley prosthesis and ten with a noncemented HP-Garches prosthesis. Tests were performed preoperatively and three, six, and 12 months postoperatively. Harris hip scores increased from a mean of 35 points preoperatively to 85 one year after surgery. Patients with a Charnley prosthesis had significantly higher scores than those with an HP-Garches prosthesis. The hip score did not differ between patients with uni- and bilateral disease. Mean maximum walking speed before surgery was 62 m/minute and increased to 80 m/minute one year after THA. The mean oxygen cost preoperatively was 0.267 ml/kg/m and decreased to 0.221 ml/kg/m one year after surgery. A weak correlation was found between differences in Harris hip scores and the corresponding oxygen cost. The onset of and the recovery from complications as well as differences between patients with uni- and bilateral diseases were reflected in changes in oxygen cost in contrast to clinical scores. The measurement of oxygen cost gave objective and valuable information about walking efficiency after THA.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2323128

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  3 in total

1.  Changes in walking ability after knee replacement.

Authors:  E Mattsson; L A Broström; D Linnarsson
Journal:  Int Orthop       Date:  1990       Impact factor: 3.075

2.  Gait analysis and hip extensor function early post total hip replacement.

Authors:  Grainne Colgan; Mike Walsh; Damien Bennett; John Rice; Timothy O'Brien
Journal:  J Orthop       Date:  2016-04-06

3.  Effects of total hip replacement on quality of life in patients with osteoarthritis and in patients with rheumatoid arthritis.

Authors:  M Borstlap; J L Zant; M Van Soesbergen; J K Van der Korst
Journal:  Clin Rheumatol       Date:  1994-03       Impact factor: 2.980

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.